| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...994834O |
| P356 | DOI | 10.1371/JOURNAL.PONE.0094834 |
| P932 | PMC publication ID | 4029574 |
| P698 | PubMed publication ID | 24847804 |
| P5875 | ResearchGate publication ID | 262540430 |
| P50 | author | Hiroki Takahashi | Q90366042 |
| Taro Narumi | Q48775749 | ||
| P2093 | author name string | Yoko Shibata | |
| Akira Fukao | |||
| Tsuneo Konta | |||
| Takeo Kato | |||
| Isao Kubota | |||
| Takanori Arimoto | |||
| Takuya Miyamoto | |||
| Tetsu Watanabe | |||
| Tetsuro Shishido | |||
| Yoshiyuki Ueno | |||
| Takamasa Kayama | |||
| Atushi Hirayama | |||
| Makoto Daimon | |||
| Shinpei Kadowaki | |||
| Yoichiro Otaki | |||
| Yuki Honda | |||
| P2860 | cites work | Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. | Q51105093 |
| New criteria for 'obesity disease' in Japan. | Q53667063 | ||
| Fatty acid binding proteins from heart. | Q53757279 | ||
| Lifetime Risk for Developing Congestive Heart Failure | Q57073232 | ||
| Apoptosis in the failing human heart | Q73215232 | ||
| Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes | Q73371663 | ||
| Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population | Q80336094 | ||
| Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure | Q80926651 | ||
| Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage | Q81257498 | ||
| Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan--first report from the CHART-2 study | Q83707405 | ||
| ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] | Q22306349 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
| Obesity, insulin resistance and cancer risk | Q28189539 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
| Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative | Q34118221 | ||
| Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients | Q34613744 | ||
| Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study | Q34768805 | ||
| Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. | Q34978591 | ||
| Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study | Q36326775 | ||
| Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 | ||
| Chronic kidney disease and cancer: a troubling connection | Q36773023 | ||
| National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 | Q36944032 | ||
| The renin-angiotensin system and cancer: old dog, new tricks. | Q37802186 | ||
| Novel biomarkers in chronic heart failure | Q37997237 | ||
| Epidemiology of heart failure in Asia | Q38129750 | ||
| Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
| Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure | Q40446768 | ||
| Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population | Q41666469 | ||
| Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. | Q42124769 | ||
| Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation | Q43520800 | ||
| Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population | Q44317661 | ||
| Myocytes die by multiple mechanisms in failing human hearts | Q44370216 | ||
| Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction | Q44473826 | ||
| Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction | Q44997767 | ||
| Sympathetic activity and myocardial damage after stimulation of dorsal medulla and vagotomy in a novel animal model | Q46442965 | ||
| Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects | Q46497475 | ||
| Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease | Q48161023 | ||
| Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure | Q48252681 | ||
| Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators | Q48455461 | ||
| Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure | Q48504834 | ||
| Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction | Q48657782 | ||
| Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention | Q48788707 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | e94834 | |
| P577 | publication date | 2014-05-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study | |
| P478 | volume | 9 |
| Q37411680 | Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up. |
| Q48353831 | Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes. |
| Q89861720 | Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death |
| Q53403792 | Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure. |
| Q92632420 | Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far? |
| Q92070947 | Heart-fatty acid binding protein in dogs with degenerative valvular disease and dilated cardiomyopathy |
| Q36323910 | Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease |
| Q35662925 | Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. |
| Q90744103 | Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases |
| Q33615459 | Novel biomarkers for cardiovascular risk prediction |
| Q36016656 | Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery |
| Q36166332 | The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study. |
| Q58695791 | The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease |
Search more.